The current valuation score of Evotec SE is 6.98, ranking 233 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.00, which is 0.00% below the recent high of -3.00 and -1395.68% above the recent low of -44.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.